Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on 18F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort.
Journal: Tomography (Ann Arbor, Mich.)
Published: December 14, 2025
Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry.
Journal: JCO precision oncology
Published: September 19, 2025
Racial Disparities in the Prescribing of Guideline-Recommended Medications for Metastatic Prostate Cancer: A Retrospective Cohort Study.
Journal: Prostate cancer
Published: March 19, 2025
Tarlatamab for Large Cell Neuroendocrine Carcinoma in a Young Adult: A Case Report.
Journal: JTO clinical and research reports
Published: June 01, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 06, 2024
Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer.
Journal: The Annals of pharmacotherapy
Published: February 12, 2024
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Journal: Cancer research communications
Published: October 16, 2023
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: June 20, 2023
Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report.
Journal: Journal of medical case reports
Published: January 17, 2022
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Journal: PloS one
Published: December 31, 2021
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: December 15, 2021
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 24, 2021
Last Updated: 09/26/2026